Centre plans separate licence regime for bulk drugs, APIs: Report

India is preparing to revamp its pharmaceutical licensing system amid growing scrutiny over drug safety lapses. Mint has learnt that the government is working on a separate wholesale licensing framework for bulk drugs, active pharmaceutical ingredients (APIs) and key starting materials (KSMs), aimed at improving oversight and traceability across the supply chain.

Three government officials familiar with the matter told Mint that a draft notification is being prepared to introduce a distinct licensing regime for raw pharmaceutical materials. The move would dismantle the existing system under which bulk drugs and finished formulations operate under a common licence. Officials said this would allow the Drugs Controller General of India (DCGI) to create a long-missing registry of nearly 1.2 million bulk drug traders, significantly strengthening accountability in the sector.

Mint reports that concerns around transparency in the raw material supply chain intensified after incidents involving cough syrups contaminated with diethylene glycol, which triggered serious safety alarms. One of the officials said closer monitoring of high-risk solvents, including propylene glycol used in formulations, has become urgent.

The proposed overhaul seeks to establish a comprehensive database of bulk drug dealers, improve traceability of imported raw materials and enable regulators to quickly identify suppliers of substandard inputs. Mint notes that more than 70% of India’s bulk drug imports originate from China. The domestic pharmaceutical market is valued at about 50 billion dollars, while the APIs, bulk drugs and advanced intermediates segment alone was worth roughly 3.5 billion dollars in FY25.

Related Posts

Operation Monsoon Thunder: NCB raids four cities, arrests six in probe into US-bound opioid and psychotropic drug shipments

New Delhi: In a sweeping international crackdown, the Narcotics Control Bureau (NCB) and the US Drug Enforcement Administration (DEA) have dismantled the Indian nerve center of a massive transnational drug…

Maharashtra FDA issues statewide compliance order for health supplements, nutraceuticals

Commissioner of Food Safety Tukaram Mundhe said inspections, consumer complaints and surveillance had repeatedly revealed violations Repeated violations of existing food safety regulations by manufacturers and sellers of health supplements…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Operation Monsoon Thunder: NCB raids four cities, arrests six in probe into US-bound opioid and psychotropic drug shipments

Operation Monsoon Thunder: NCB raids four cities, arrests six in probe into US-bound opioid and psychotropic drug shipments

Maharashtra FDA issues statewide compliance order for health supplements, nutraceuticals

Maharashtra FDA issues statewide compliance order for health supplements, nutraceuticals

Karnataka High Court quashes case against MedPlus over short supply of one tablet costing ₹1.12

Karnataka High Court quashes case against MedPlus over short supply of one tablet costing ₹1.12

Fake epilepsy, diabetes drugs made using chalk, lactose at illegal Himachal factory; 2 held

Fake epilepsy, diabetes drugs made using chalk, lactose at illegal Himachal factory; 2 held

Without Skipping a Beat: Surgical Robot SSiMantra powers Landmark Beating Heart Bypass

Without Skipping a Beat: Surgical Robot SSiMantra powers Landmark Beating Heart Bypass

Drug Department Raids Patna’s Govind Mitra Road Medicine Market Over Suspected Illegal Sale Of Medicines

Drug Department Raids Patna’s Govind Mitra Road Medicine Market Over Suspected Illegal Sale Of Medicines